BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity

W Wang Gong H Hülya F. Taner Y Yuesong Wu Y Yumin He X Xingwu Zhou (Department of Pharmaceutical Sciences, University of Michigan) Z Zaiye Li (Department of Cancer Biology, The University of Texas MD Anderson Cancer Center) X Xin Hu C Charisse Ursin K Kala Chand Debnath K Kohei Okuyama Q Qiang Hu C Christopher R. Donnelly F Felipe Nor C Chamila D. Perera E Emily Bellile A Arash Yunesi Z Zhiqian Zhai M Mei Zhao W Wanqing Cheng Z Zackary R. Fitzsimonds (Department of Oral Immunology and Infectious Diseases, University of Louisville) L Luke Broses J Jiaqian Li S Shadmehr Demehri D Deepak Nagrath G Gregory T. Wolf A Andrew G. Sikora Y Yanbao Yu H Haitao Wen L Lei Wei (School of Physical Science and Technology, Shanghai Key Laboratory of High-Resolution Electron Microscopy, State Key Laboratory of Advanced Medical Materials and Devices) S Steven B. Chinn J Jeffrey N. Myers S Shizuo Akira Y Yuying Xie J James J. Moon (Department of Pharmaceutical Sciences, University of Michigan) Y Yu Leo Lei (Department of Cancer Biology, The University of Texas MD Anderson Cancer Center)